---
title: "Odyssey Health extends two note maturities to January 2027"
url: "https://aibio.space/news/odyssey-health-extends-two-note-maturities-january-2027/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-09-29"
section: "Debt Financing"
tickers: "OTC:ODYY"
source: "https://www.sec.gov/Archives/edgar/data/1626644/000168316826007625/odyssey_8k.htm"
summary: "Two notes held by LGH Investments, LLC and Peter J. D'Arruda now mature on January 31, 2027. All other terms stay the same, the filing says."
---

By the aibio.space news desk.

Sources

- [Odyssey Health, Inc. 8-K (2026-10-05)](https://www.sec.gov/Archives/edgar/data/1626644/000168316826007625/odyssey_8k.htm)

[ODYY](https://aibio.space/companies/odyssey-health/)

2026-09-29

# Odyssey Health extends two note maturities to January 2027

Tickers [ODYY](https://aibio.space/companies/odyssey-health/)

Two notes held by LGH Investments, LLC and Peter J. D'Arruda now mature on January 31, 2027. All other terms stay the same, the filing says.

## Key facts

- **Company**: Odyssey Health, Inc. (OTC: ODYY)

- **News type**: Debt Financing

- **Primary source**: [Odyssey Health, Inc. 8-K (2026-10-05)](https://www.sec.gov/Archives/edgar/data/1626644/000168316826007625/odyssey_8k.htm)

*A city skyline seen across a river. Photo: Matt Bango, CC0, via StockSnap. The picture shows the field, not the companies named.*

Odyssey Health, Inc. said it signed two amendments on September 29, 2026 that extend the maturity date of two promissory notes to January 31, 2027. The report was filed on October 5, 2026.

The first is Amendment No. 13 to a convertible promissory note dated April 5, 2021 with LGH Investments, LLC. The second is Amendment No. 1 to a promissory note dated October 1, 2025 with Peter J. D'Arruda, an accredited investor. The filing names LGH Investments, LLC and Peter J. D'Arruda as the note holders.

According to the filing, all other terms and conditions of both notes remain the same. The filing does not describe any change in principal, any change in interest rate or any new funds.

The form of each amendment is attached to the report as an exhibit. Joseph Michael Redmond, chief executive officer, signed the report. The filing names no placement agent or advisor.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

ODYY

Odyssey Health, Inc.

OTC · United States

Open the starter desk

## More in Debt Financing

Debt Financing

### [Pelthos amends Horizon venture loan, funds Loans E to H and adds Loans I and J](https://aibio.space/news/pelthos-amends-horizon-venture-loan-funds-loans-e-h-adds-loans/)

Oct 30, 2026

Debt Financing

### [Repligen announces $1.0 billion private convertible notes transaction](https://aibio.space/news/repligen-announces-1-0-billion-private-convertible-notes-transaction/)

Oct 30, 2026

Debt Financing

### [FOXO to buy Ludwig Enterprises preferred stock with majority voting power](https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/)

Oct 29, 2026

---
Source page: https://aibio.space/news/odyssey-health-extends-two-note-maturities-january-2027/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Odyssey Health extends two note maturities to January 2027", 2026-09-29, https://aibio.space/news/odyssey-health-extends-two-note-maturities-january-2027/